****
Mission Bio, the leader in single-cell DNA sequencing and multi-omics to accelerate discoveries and improve time-to-market for new therapeutics
Mission Bio’s Tapestri Platform is the first single-cell multi-omics platform capable of detecting DNA and protein changes simultaneously. It gives a profound insight into the mutations and immunophenotypes that drive disease to enable faster, more successful development of precision therapies.
Intricately woven, cancer and other illnesses challenge us with complexity. With Mission Bio, you can carefully tease apart each strand – genotype, phenotype, cell types, co-occurring mutations, zygosity, and structural changes – for a more holistic view of biology, revealing more meaningful sources of disease. Providing cancer researchers with the only single-cell multi-omics solution that simultaneously detects SNV, CNV, and protein data from the same cell.
About Mission Bio
Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. In 2014, the company was spun out of Adam Abate’s lab for high-throughput biology at the University of California, San Francisco (UCSF). Mission Bio’s precision genomics platform is based on the pioneering droplet microfluidics work of Abate and his team. The mission is to help researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine.
English (UK)